Resources from the same session
39O - Four years and 1400+ patient referrals: Achievements of the Australian Rare Cancer Portal
Presenter: Betty Zhang
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session 1
Resources:
Webcast
52O - Resistance to imatinib induced by treatment interruption in advanced GIST: Long-term outcome of the randomized BFR14 study
Presenter: Quentin Devin
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
53O - Results from a phase II part I trial of mecbotamab vedotin (BA3011), a CAB-AXL-ADC, in patients with advanced refractory sarcoma
Presenter: Seth Pollack
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
54O - Health state impacts of afamitresgene autoleucel (afami-cel) in advanced synovial sarcoma and myxoid/round cell liposarcoma: SPEARHEAD-1 cohort 1
Presenter: Michael Wagner
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 52O, 53O and 54O
Presenter: Hanna Kosela Paterczyk
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session 1
Resources:
Webcast